Tomokazu Oyama
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiovascular Health and Disease Prevention, Lipoproteins and Cardiovascular Health, Blood Pressure and Hypertension Studies, Pharmacology and Obesity Treatment
Most-Cited Works
- → Contradictory Effects of β1- and α1- Aderenergic Receptor Blockers on Cardio-Ankle Vascular Stiffness Index (CAVI)(2011)189 cited
- → Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy(2005)112 cited
- → Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity(2004)82 cited
- → Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome(2006)82 cited
- → Circulating angiotensin II is associated with body fat accumulation and insulin resistance in obese subjects with type 2 diabetes mellitus(2009)80 cited
- → Effects of Pitavastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, on Cardio-Ankle Vascular Index in Type 2 Diabetic Patients(2009)78 cited
- → Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients(2010)75 cited
- → Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension(2009)75 cited
- → Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy(2009)70 cited
- → Effects of body weight reduction on cardio-ankle vascular index (CAVI)(2011)69 cited